Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
adjudicated, adolescent, ahead, alongside, appeal, arbitrage, arbitrarily, arbitrary, archived, Arrowhead, Asa, attrition, Aviceda, awaiting, Belite, beneficiary, BLA, bolster, boost, Bulletin, Canadian, capriciously, caption, certiorari, chose, CODM, commensurate, compact, compensatory, complaint, Consortium, constitutionality, contrary, Cowen, crossed, curve, decree, destined, disaggregated, dismissed, doctor, dysfunctional, East, effectuated, enjoined, Erosion, escalation, exact, expert, Fabhalta, FY, FYs, GB, GloBE, guideline, head, highlighting, HTA, infeasible, instruction, Izervay, Jersey, Judith, magnitude, Merck, Michigan, Middle, mifepristone, mobile, morale, motion, navigate, Nevada, nonsubfoveal, notional, Ocugen, OECD, onsite, organizational, Parliament, password, path, pave, PAYGO, PHI, PhRMA, PIE, plaintiff, Postmarketing, preexisting, preparatory, print, purported, quantitative, Ray, reconciling, resurgence, sequestration, Soderberg, stay, stayed, strongly, sue, TCA, thereon, threshold, topline, transposed, truthful, TV, unbiased, uncompensated, unexpired, unmarketability, unscheduled, unwind, unwinding, USPI, vigorously, Washington, Windsor, writ
Removed:
agglutinate, alkylating, Amylyx, ARC, ascending, ASU, avacopan, Avanir, bilirubin, biology, blinded, breathing, calculate, calculating, calibrated, CFI, ChemoCentryx, clinic, clonal, closed, clump, commencing, Conference, confirmation, continually, continuation, convince, COSO, COVID, descent, devastating, dextromethorphan, disrupted, edaravone, elderly, elevated, exhaust, expression, fallen, FFCR, Gyroscope, half, Hb, histopathological, hoc, host, IgM, immunoglobin, IMPD, installment, intravenously, ITF, Iveric, Japanese, junction, logistical, missed, Mitsubishi, modifying, motor, movement, muscle, nerve, neurodegenerative, neuroinflammation, neurological, neuromuscular, Nuedexta, offshore, opening, outbreak, PADDOCK, participant, Patch, paused, PD, PHAROAH, PK, PLAUDIT, prioritization, productivity, Radicava, rank, reclassified, recruit, redirect, remeasured, remotely, repatriated, repealing, retroactively, revealed, riluzole, rollforward, Sanofi, scenario, sooner, speaking, spiked, splenectomy, sporadic, spread, stroke, sublicensee, Subtopic, sulfate, suspended, swallowing, Tanabe, temporarily, thickened, Tiglutik, toxicological, transitioned, unprotected, unwilling, upcoming, walking, worker, worsening
Filing tables
Filing exhibits
Associated APLS transcripts
APLS similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Apellis Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the year ending December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Cedric Francois, the Chief Executive Officer and President of the Company, hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: February 27, 2024 | By: | /s/ Cedric Francois | |
Cedric Francois | |||
Chief Executive Officer and President |